Market research and analysis

Prior to market entry of any Rare Disease Treatment, it is essential to acknowledge and identify the multi-stakeholder profile of the Rare Disease market environment while having clear and strict scientific criteria for the quantifiable prevalence that constitutes the eligible pool of patients

Market access coordination

Payers and policymakers are constantly revising the mechanisms and processes relating to reimbursement decisions for Rare Disease treatments. There is, as yet, little consensus on the best approach for assessing the value and determining the appropriate price of Rare Disease treatments. An unbalance is created between payors affordability and access to valuable treatments at the expense of the Rare Disease patient

Marketing and sales execution

With our overarching Rare Disease mindset our aim is to synthesize tailored marketing strategies to incorporate a wholistic approach around the rare disease patient journey. An implementation plan to accompany our shaped strategy becomes vital to action and accountability

Regulatory and PV

At Ardius Pharma we fully understand the importance of regulatory and pharmacovigilance compliance throughout a product’s lifecycle and can provide comprehensive support and assistance in this area.


  • Secure seamless physical distribution
  • Comply with the storage and distribution conditions
  • Minimize delivery time